Science and Technology

Scientists intend to create a human simulator for drug testing

Scientists intend to create a simulator of the human body for testing drugs. The new technology will allow drug manufacturers to quickly test new drugs

07 August 2012, 12:04

Slimming perfume is already a cherished dream of British women

The world's first perfume that helps you lose weight was created by French perfumers.

07 August 2012, 10:36

The U.S. has begun using digital micro-pills

The US Food and Drug Administration (FDA) has approved the use of a so-called digital micropill in medical practice in the country.

07 August 2012, 09:10

Chemotherapy may cause cancer cells to become resistant to drugs

Chemotherapy used to treat cancer can make cancer cells more resistant to drugs.

06 August 2012, 23:44

How have scientists gotten closer to creating an HIV vaccine?

For a long time, all countries of the world have been working on developing a vaccine that will help save millions of people from HIV infection.

06 August 2012, 21:33

A new mechanism for the development of type 2 diabetes has been discovered

Human neutrophils play a completely unexpected role as modulator of insulin resistance, a key characteristic of type 2 diabetes

06 August 2012, 19:42

Humans have developed immunity to rabies.

Several Peruvians have survived rabies, although no one has treated them.

03 September 2012, 15:17

New technique based on electric current effectively fights obesity

A new method has been discovered that can radically combat fat deposits. And it works based on the principle of influencing fat cells with electric current.

06 August 2012, 15:31

Natural plant substance prevents the development of breast cancer

The natural plant substance phenethyl isothiocyanate (PEITC) inhibits the development of mammary tumors in GM mice "rewarded" with advanced breast cancer similar to human cancer.

06 August 2012, 14:32

Proven efficacy of a spray with skin cells in the treatment of trophic ulcers

A topical spray containing skin cells, developed by the American company Healthpoint Biotherapeutics, was tested on 228 patients with trophic ulcers.

06 August 2012, 13:17